{
    "Trade/Device Name(s)": [
        "Sentinel Pancreatic Amylase"
    ],
    "Submitter Information": "Sentinel CH. Srl",
    "510(k) Number": "K051447",
    "Predicate Device Reference 510(k) Number(s)": [
        "K895880"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JFJ"
    ],
    "Summary Letter Date": "January 3, 2006",
    "Summary Letter Received Date": "January 12, 2006",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1070"
    ],
    "Regulation Name(s)": [
        "Amylase test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Pancreatic amylase"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "AEROSET analyzer",
        "ARCHITECT c8000 analyzer",
        "Hitachi 911 analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "In vitro diagnostic assay",
        "Enzymatic activity measurement",
        "Two-reagent format"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Sentinel Pancreatic Amylase assay for quantitative determination of pancreatic amylase in serum or plasma using a two-reagent enzymatic method.",
    "Indications for Use Summary": "Quantitation of pancreatic amylase levels in human serum or plasma to aid in diagnosis and treatment of pancreatitis; for in vitro use only.",
    "fda_folder": "Clinical Chemistry"
}